Anti-mouse/human/rat CD47 (IAP)-InVivo [MIAP410]

製品コードA2140 Clone NO.：MIAP410 純度：99%

Anti-mouse/human/rat CD47 (IAP)-InVivo [MIAP410] reacts with mouse CD47 otherwise known as integrin-associated protein (IAP). CD47 is an approximately 50 kDa glycosylated five transmembrane protein that is ubiquitously expressed by both hematopoietic cells such as T and B lymphocytes, monocytes, platelets and erythrocytes and non-hematopoietic cells.

サイズ（液体）	価格(税別)	在庫状況
1mg	JPY 14500	国内在庫あり
5mg	JPY 53600	国内在庫あり
5mg*5	JPY 177500	お問い合わせ
5mg*20	JPY 379600	お問い合わせ

代表番号: 045-509-1970\|電子メール：sales@selleck.co.jp よく尋ねられる質問

クリックしてAnti-mouse/human/rat CD47 (IAP)-InVivo [MIAP410]のアイソタイプコントロールを購入する

質量管理及び製品安全説明書

現在のバッチを見る：純度： 99% タンパク質濃度： 6.07 mg/ml 内毒素：＜1EU/mg

製品説明

Clone	MIAP410
Formulation	PBS, pH 7.0 Contains no stabilizers or preservatives
Isotype	Mouse IgG1, κ
Application	Anti-mouse/human/rat CD47 (IAP)-InVivo
Source	CHO
Murine Pathogen Screening Panel	all targets tested yielded Negative Results: Theiler’s Murine Encephalomyelitis Virus, Ectromelia (Mousepox) Virus, Hantavirus, Polyomavirus, Sendai Virus, Mycoplasma pulmonis, Pneumonia Virus of Mice, K Virus, Mouse Parvovirus, Mouse Hepatitis Virus, Mouse Norovirus, Mouse Minute Virus, Mouse Cytomegalovirus, Mouse Adenovirus, Lactate Dehydrogenase-Elevating Virus, Reovirus Panel, Lymphocytic Choriomeningitis Virus, Mouse Rotavirus.
Storage (From the date of receipt)	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Shipping	Shipped under low temperature conditions
Purification	Protein G
Sterility	0.2 μM filtered

各種クローンの論文数比較

^*Selleckは、市場の主要なクローンを収集し、2024年9月までの文献での使用状況を調査しました。その結果、Selleckの選定クローンが最も広く使用されていることが示されました。

臨床試験

NCT Number	Recruitment	interventions	Conditions	Sponsor/Collaborators	Start Date	Phases
NCT05082259	ACTIVE_NOT_RECRUITING	Drug: ASTX660\|Drug: Pembrolizumab	Advanced Cancer; Cervical Cancer; Triple Negative Breast Cancer	Institute of Cancer Research, United Kingdom	2022-03-02	PHASE1
NCT06224868	UNKNOWN		Cholecystitis	Baskent University	2024-01-15
NCT03871959	COMPLETED	Drug: Pembrolizumab\|Drug: DEBIO1143	Adenocarcinoma of the Pancreas; Adenocarcinoma of the Colon; Adenocarcinoma of the Rectum	Centre Leon Berard	2019-09-15	PHASE1
NCT03547986	UNKNOWN		Peripheral Arterial Disease	Biotronik AG	2018-11-09
NCT01908413	TERMINATED	Drug: CUDC-427	Lymphoma	Curis, Inc.	2013-07	PHASE1
NCT01831232	COMPLETED	Drug: pravastatin sodium\|Drug: idarubicin\|Drug: cytarabine	Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Chronic Myelomonocytic Leukemia; de Novo Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Refractory Anemia With Excess Blasts; Untreated Adult Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	2013-05

(data from https://clinicaltrials.gov, updated on 2026-06-25)

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

* 必須